Hemophilia Patients Call For US FDA Hearing To Assure Access To Hemlibra

Patients submit citizen petition in response to Shire's request for preliminary injunction in patent dispute with Genentech, calling it...

      

Related Stories

• FDA’s Tactical Exparel Label May Suggest Broader Off-Label Strategy
• Portugal Uses Horizon Scanning To Speed Up Market Entry For Innovative Drugs
• ATMP For Metastatic Cervical Cancer Among Nine New Products Under EMA Review

 

Original Article: Hemophilia Patients Call For US FDA Hearing To Assure Access To Hemlibra

More From BioPortfolio on "Hemophilia Patients Call For US FDA Hearing To Assure Access To Hemlibra"